Work

C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade

Year: 2011

Type: article

Source: Life Sciences

DOI: 10.1016/j.lfs.2011.07.009

Authors: Brian Casserly, Jeffrey M. Mazer, Alexander Vang, Elizabeth O. Harrington, James R. Klinger, Sharon Rounds, Gaurav Choudhary

Institutions: Brown University, Providence VA Medical Center

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Office of Research and Development, National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: G1671519669, Endothelial Barrier Function Modulation by PKCDelta, G3471846259, G5288627780, Small GTPases and Lung Endothelial Apoptosis

OpenAlex ID: W2007500531

FWCI: 0.544

Cites: 47

Cited by: 13

Related to: 10